Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292


Real-time Estimate Quote. Real-time Estimate Cboe Europe - CXE - 03/05 11:30:00 am
6849.5 GBX   -0.11%
11:05aTHE LATEST : Canada OKs J&J, getting 4th vaccine for nation
10:34aCanada clears Johnson & Johnson vaccine, first to approve 4
10:24aGLOBAL MARKETS LIVE: Boeing, Broadcom, Costco…
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Exclusive: India to begin commercial vaccine exports with shipments to Brazil, Morocco

01/21/2021 | 10:50pm EST
FILE PHOTO: A woman holds a medical syringe and a small bottle labelled

NEW DELHI (Reuters) - India's government has cleared commercial exports of COVID-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the Indian foreign secretary told Reuters.

The shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at the Serum Institute of India, the world's biggest producer of vaccines, which has received orders from countries across the world.

The Indian government had held off exporting doses until it began its own domestic immunisation programme last weekend. Earlier this week, it sent free supplies to neighbouring countries including Bhutan, Maldives, Bangladesh and Nepal.

Foreign Secretary Harsh Vardhan Shringla said commercial supplies of the vaccine would begin from Friday in line with Prime Minister Narendra Modi's commitment that India's production capacities would be used for all of humanity to fight the pandemic.

"In keeping with this vision, we have responded positively to requests for supply of Indian manufactured vaccines from countries across the globe, starting with our neighbours," he said, referring to the free supplies.

"Supply of commercially contracted quantities will also commence from tomorrow, starting with Brazil and Morocco, followed by South Africa and Saudi Arabia," he added.

Brazil, which has world's second-highest COVID-19 death toll after the United States, has been urging India to send the AstraZeneca vaccine. It has agreed to take 2 million doses from Serum and was ready to send a plane last week to pick them up.

Morocco, South Africa and Saudi Arabia have also secured supplies from Serum, officials said.

(Reporting by Sanjeev Miglani; Editing by Pravin Char)

By Sanjeev Miglani

© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.03% 6868 Delayed Quote.-6.38%
DOW JONES AFRICA TITANS 50 INDEX -0.05% 516.34 Delayed Quote.-1.79%
DOW JONES SOUTH AFRICA(ZAR) 0.68% 2002.65 Delayed Quote.12.80%
EURO / BRAZILIAN REAL (EUR/BRL) -0.29% 6.7775 Delayed Quote.6.73%
S&P AFRICA 40 INDEX 0.21% 169.58 Delayed Quote.-1.43%
All news about ASTRAZENECA PLC
11:05aTHE LATEST : Canada OKs J&J, getting 4th vaccine for nation
10:34aCanada clears Johnson & Johnson vaccine, first to approve 4
10:24aGLOBAL MARKETS LIVE: Boeing, Broadcom, Costco…
10:09aWhat you need to know about Johnson & Johnson's approved single-dose vaccine
09:59aASTRAZENECA  : Africa welcomes COVAX doses but warns against 'selfishness'
09:55aASTRAZENECA  : France backs Italy in vaccine ban as EU defends mechanism
09:31aEXCLUSIVE : Oxford study indicates AstraZeneca effective against Brazil variant,..
09:29aASTRAZENECA  : After mixed messages, Europe warns against vaccine shopping
08:36aTHE LATEST : AP poll: Americans back Biden's virus response
08:01aASTRAZENECA  : Indian vaccine giant SII warns of supply hit from U.S. raw materi..
More news
Financials (USD)
Sales 2021 30 741 M - -
Net income 2021 4 686 M - -
Net Debt 2021 11 138 M - -
P/E ratio 2021 26,3x
Yield 2021 2,99%
Capitalization 125 B 126 B -
EV / Sales 2021 4,43x
EV / Sales 2022 3,86x
Nbr of Employees 76 100
Free-Float 95,8%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 25
Average target price 129,17 $
Last Close Price 95,25 $
Spread / Highest target 65,0%
Spread / Average Target 35,6%
Spread / Lowest Target -0,42%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC-6.38%125 912
JOHNSON & JOHNSON-2.74%402 372
ROCHE HOLDING AG-1.63%282 130
NOVARTIS AG-6.52%190 880
PFIZER INC.-6.57%190 813
ABBVIE INC.-1.40%186 565